Cargando…
The ability of early changes in motivation to predict later antidepressant treatment response
INTRODUCTION: Baseline values and early changes of emotional reactivity, cognitive speed, psychomotor function, motivation, and sensory perception have not been studied to any extent in unipolar depression, although they could help to characterize different dimensions of illness that are harder to c...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646593/ https://www.ncbi.nlm.nih.gov/pubmed/26635476 http://dx.doi.org/10.2147/NDT.S92795 |
_version_ | 1782400957545447424 |
---|---|
author | Gorwood, Philip Vaiva, Guillaume Corruble, Emmanuelle Llorca, Pierre-Michel Baylé, Franck J Courtet, Philippe |
author_facet | Gorwood, Philip Vaiva, Guillaume Corruble, Emmanuelle Llorca, Pierre-Michel Baylé, Franck J Courtet, Philippe |
author_sort | Gorwood, Philip |
collection | PubMed |
description | INTRODUCTION: Baseline values and early changes of emotional reactivity, cognitive speed, psychomotor function, motivation, and sensory perception have not been studied to any extent in unipolar depression, although they could help to characterize different dimensions of illness that are harder to capture by clinicians, give new insights on how patients improve, and offer new early clinical markers for later treatment response. METHODS: About 1,565 adult outpatients with major depressive disorder receiving agomelatine completed the clinician-rated 16-item quick inventory of depressive symptoms, Clinical Global Impression, and Multidimensional Assessment of Thymic States (MAThyS) rating scales at inclusion, Week 2 and Week 6. The MAThyS includes a 20-item self-rated visual analog scale (from inhibition [0] to activation [10], with [5] representing the usual state) leading to five a priori dimensions (emotional reactivity, cognitive speed, psychomotor function, motivation, and sensory perception). RESULTS: All MAThyS dimension scores increased from inclusion to Week 2 and from inclusion to Week 6 (P<0.001). Improvement was around 2 points (out of 10) for motivation, 1.5 points for psychomotor function, and 0.5 points for other dimensions. Motivation showed a trend to being more severely impaired at inclusion in future nonresponders (t=1.25, df=1,563, P=0.10). Its improvement at Week 2 was the most discriminating MAThyS dimension between future responders and nonresponders, and represents the best predictor of future response, with the highest area under the receptor operating characteristic curve (area under curve =0.616, 95% confidence interval [0.588–0.643], P<0.001). Finally, improvements in motivation correlated the most strongly with clinician-rated 16-item quick inventory of depressive symptoms improvement (r=−0.491, df=1,563, P<0.001). CONCLUSION: Motivation had the most capacity for early improvement, the best predictive value for response, and the largest global margin of progress in depressed outpatients. Assessing the evolution of self-reported motivation over time in major depressive disorder could offer an interesting complementary approach to predict response. |
format | Online Article Text |
id | pubmed-4646593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-46465932015-12-03 The ability of early changes in motivation to predict later antidepressant treatment response Gorwood, Philip Vaiva, Guillaume Corruble, Emmanuelle Llorca, Pierre-Michel Baylé, Franck J Courtet, Philippe Neuropsychiatr Dis Treat Original Research INTRODUCTION: Baseline values and early changes of emotional reactivity, cognitive speed, psychomotor function, motivation, and sensory perception have not been studied to any extent in unipolar depression, although they could help to characterize different dimensions of illness that are harder to capture by clinicians, give new insights on how patients improve, and offer new early clinical markers for later treatment response. METHODS: About 1,565 adult outpatients with major depressive disorder receiving agomelatine completed the clinician-rated 16-item quick inventory of depressive symptoms, Clinical Global Impression, and Multidimensional Assessment of Thymic States (MAThyS) rating scales at inclusion, Week 2 and Week 6. The MAThyS includes a 20-item self-rated visual analog scale (from inhibition [0] to activation [10], with [5] representing the usual state) leading to five a priori dimensions (emotional reactivity, cognitive speed, psychomotor function, motivation, and sensory perception). RESULTS: All MAThyS dimension scores increased from inclusion to Week 2 and from inclusion to Week 6 (P<0.001). Improvement was around 2 points (out of 10) for motivation, 1.5 points for psychomotor function, and 0.5 points for other dimensions. Motivation showed a trend to being more severely impaired at inclusion in future nonresponders (t=1.25, df=1,563, P=0.10). Its improvement at Week 2 was the most discriminating MAThyS dimension between future responders and nonresponders, and represents the best predictor of future response, with the highest area under the receptor operating characteristic curve (area under curve =0.616, 95% confidence interval [0.588–0.643], P<0.001). Finally, improvements in motivation correlated the most strongly with clinician-rated 16-item quick inventory of depressive symptoms improvement (r=−0.491, df=1,563, P<0.001). CONCLUSION: Motivation had the most capacity for early improvement, the best predictive value for response, and the largest global margin of progress in depressed outpatients. Assessing the evolution of self-reported motivation over time in major depressive disorder could offer an interesting complementary approach to predict response. Dove Medical Press 2015-11-11 /pmc/articles/PMC4646593/ /pubmed/26635476 http://dx.doi.org/10.2147/NDT.S92795 Text en © 2015 Gorwood et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Gorwood, Philip Vaiva, Guillaume Corruble, Emmanuelle Llorca, Pierre-Michel Baylé, Franck J Courtet, Philippe The ability of early changes in motivation to predict later antidepressant treatment response |
title | The ability of early changes in motivation to predict later antidepressant treatment response |
title_full | The ability of early changes in motivation to predict later antidepressant treatment response |
title_fullStr | The ability of early changes in motivation to predict later antidepressant treatment response |
title_full_unstemmed | The ability of early changes in motivation to predict later antidepressant treatment response |
title_short | The ability of early changes in motivation to predict later antidepressant treatment response |
title_sort | ability of early changes in motivation to predict later antidepressant treatment response |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646593/ https://www.ncbi.nlm.nih.gov/pubmed/26635476 http://dx.doi.org/10.2147/NDT.S92795 |
work_keys_str_mv | AT gorwoodphilip theabilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse AT vaivaguillaume theabilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse AT corrubleemmanuelle theabilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse AT llorcapierremichel theabilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse AT baylefranckj theabilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse AT courtetphilippe theabilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse AT gorwoodphilip abilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse AT vaivaguillaume abilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse AT corrubleemmanuelle abilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse AT llorcapierremichel abilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse AT baylefranckj abilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse AT courtetphilippe abilityofearlychangesinmotivationtopredictlaterantidepressanttreatmentresponse |